Search alternatives:
significantly linked » significantly longer (Expand Search), significantly altered (Expand Search), significantly higher (Expand Search)
linked decrease » marked decrease (Expand Search), linear decrease (Expand Search)
point decrease » point increase (Expand Search)
significantly linked » significantly longer (Expand Search), significantly altered (Expand Search), significantly higher (Expand Search)
linked decrease » marked decrease (Expand Search), linear decrease (Expand Search)
point decrease » point increase (Expand Search)
-
1
-
2
-
3
-
4
-
5
-
6
-
7
-
8
-
9
MiR-129-5p levels were decreased in mouse depression models.
Published 2025“…The Y-axis represents the fold change, while the X-axis indicates the significance of differential expression. The gray points represent miRNAs with no significant change (p < 0.05, false discovery rate (FDR) q < 0.05), while red and blue points indicate upregulated and downregulated miRNAs (p < 0.05, FDR q < 0.05), respectively. …”
-
10
-
11
The strength of the commute time-functional connectivity relationship demonstrates weak pathological significance and weak dependency on age.
Published 2025“…</b> Strengthening commute time-FC correlations shown in <b>B</b> seem to be driven by a decrease in average commute time across age. Note that all reported correlations are calculated by considering all data points, i.e., they are not calculated for the binned data.…”
-
12
-
13
-
14
-
15
Cinacalcet administered early in the inactive phase markedly decrease parathyroid Ki-67 index.
Published 2025“…All groups were compared by Kruskal Wallis test with <i>post hoc</i> test after Dunn with Bonferroni adjustment showing significant decreased Ki-67 labeling index of <i>Cina1</i> compared to <i>Cina2</i> (p = 0.006) and the untreated CKD groups (p = 0.0001 and p = 0.0002, respectively). …”
-
16
Summary of post-treatment disease course measures from MDMA-AT publications.
Published 2025Subjects: -
17
-
18
Summary of post-treatment CAPS score changes from clinical trials with FDA-approved medications.
Published 2025Subjects: -
19
-
20